Assessment of Pyrazinamide-Associated Hyperuricemia Among Multidrug-Resistant Tuberculosis Patients Receiving Pyrazinamide-Containing Regimens: A Retrospective Cross-Sectional Study from Sudan
Mayada E. Abdelrahman, Fatima S. Naim, Mawahib A. Mustafa, Elkhanssa Abdelhameed Ahmed Elhag, Mohammed H. Alnazeer, Kannan O. Ahmed, Orwa Siddig & Bashir A. Yousef · Journal of Advances in Medical and Pharmaceutical Sciences · 2025
Background: Tuberculosis (TB) is still one of the most important causes of morbidity and mortality worldwide. The problem multiplies whenever there is multidrug-resistant TB (MDR-TB), due to Mycobacterium tuberculosis susceptibility to both Rifampicin and Isoniazid. Pyrazinamide...
Open access
Research Article
10.9734/jamps/2025/v27i12834